China Digest: Nutshell raises $40m Series A+ round; UniXell closes $31.5m
Biotech startups Nutshell Therapeutics and UniXell have both raised new funding to advance pipeline products.
Nutshell Therapeutics Shanghai Unixell Biotechnology Genesis Capital Hengxu Capital Source Code Capital Kunlun Capital
Source: dealstreetasia.com